| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf57f5d6ba64a8540567bd58450793b6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
1974-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_286aba58e482a77997523fb791ce3193 |
| publicationDate |
1975-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3920824-A |
| titleOfInvention |
Stable ophthalmic formulation |
| abstract |
where R is methyl or ethyl and pharmaceutically acceptable salts thereof, and its method of making. The formulation may be used therapeutically to temporarily alleviate the symptoms of glaucoma. A stabilized, topical ophthalmic formulation containing a compound having the formula |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5356885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9423719-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004019012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5637731-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5521210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0510333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5550257-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5451685-A |
| priorityDate |
1974-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |